Research › Fact Sheets › CNC

CENTENE CORP

LISTEDNYSE

SYMBOLCNC

SIC6324

STATE OF INC.DE

FISCAL YEAR ENDSDecember 31

CIK1071739

HOSPITAL & MEDICAL SERVICE PLANS · LARGE ACCELERATED FILER · 10 FISCAL YEARS OF SEC XBRL DATA, 2016–2025

Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.

CAPITALIZATION 12/31/25

($ millions)	Amount	%
Total debt	17,493	46.7
Stockholders' equity	19,953	53.3
Total capitalization	37,446	100.0

493,995,000 shares outstanding at 24 July 2026 (cover page of the 10-Q filed 28 July 2026).

LONG-TERM DEBT 12/31/25

($ millions)	Amount
Long-term debt, incl. current maturities	17,493
Long-term debt, noncurrent	17,351
Current maturities	50

CAPITAL STOCK 12/31/25

Common shares authorized	800,000,000
Common shares issued	623,463,000
Treasury shares	131,706,000
Par or stated value per share ($)	0.001
Preferred stock ($ millions)	0
Outstanding at 7/24/26	493,995,000

DIVIDENDS DECLARED/PAID

Fiscal year	Per share $	Payout %
2025	–	–
2024	–	–
2023	–	–
2022	–	–
2021	–	–

HISTORY AND BUSINESS

HISTORY: Incorporated in Delaware.

BUSINESS: Classified by the SEC under Standard Industrial Classification 6324, Hospital & Medical Service Plans. Large accelerated filer. Principal executive office: 7700 Forsyth Blvd., St Louis, MO 63105. Fiscal year ends December 31. For a description of the business, see Item 1 of the latest 10-K.

CONSOLIDATED INCOME ACCOUNT, YEARS ENDED

($ millions)	12/31/25	12/31/24	12/31/23
Total revenues	194,777	163,071	153,999
Benefits, losses and expenses	157,702	125,707	118,894
Income before income taxes	(6,728)	4,257	3,598
Income taxes	(51)	963	899
Net income	(6,674)	3,305	2,702
Earned per share, diluted ($)	(13.53)	6.31	4.95
Dividends per share ($)	–	–	–

CONSOLIDATED BALANCE SHEET

($ millions)	12/31/25	12/31/24
Total investments	17,035	17,429
Cash and equivalents	17,888	14,063
Total assets	76,747	82,445
Policy liabilities and reserves	20,544	18,308
Debt	17,493	18,640
Total liabilities	56,691	55,935
Stockholders' equity	19,953	26,410

TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)

Fiscal year ended	Revenues	Oper. income	Net income	Net margin %	EPS diluted $	Div. per share $	Oper. cash flow	Total assets	Total liabilities	Total debt	Deposits	Stockholders' equity	ROE %	Debt / equity
12/31/25	194,777	(7,623)	(6,674)	-3.4	(13.53)	–	5,088	76,747	56,691	17,493	–	19,953	-33.4	0.88
12/31/24	163,071	3,175	3,305	2.0	6.31	–	154	82,445	55,935	18,640	–	26,410	12.5	0.71
12/31/23	153,999	2,930	2,702	1.8	4.95	–	8,053	84,641	58,685	17,962	–	25,840	10.5	0.70
12/31/22	144,547	1,318	1,202	0.8	2.07	–	6,261	76,870	52,633	18,179	–	24,057	5.0	0.76
12/31/21	125,982	1,784	1,347	1.1	2.28	–	4,205	78,375	51,353	19,026	–	26,795	5.0	0.71
12/31/20	111,115	3,082	1,808	1.6	3.12	–	5,503	68,719	42,757	16,880	–	25,773	7.0	0.65
12/31/19	74,639	1,781	1,321	1.8	3.14	–	1,483	40,994	28,302	13,859	–	12,551	10.5	1.10
12/31/18	60,116	1,458	900	1.5	2.26	–	1,234	30,901	19,878	6,851	–	10,917	8.2	0.63
12/31/17	48,382	1,199	828	1.7	2.34	–	1,489	21,855	14,979	4,829	–	6,850	12.1	0.70
12/31/16	40,607	1,263	562	1.4	1.71	–	1,851	20,197	14,143	4,782	–	5,895	9.5	0.81

Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; capital expenditure and free cash flow are not shown for banks and insurers, where they are not meaningful; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.

REGISTRANT:

CENTENE CORP
CIK 1071739 · EIN 04-1406317

PRINCIPAL OFFICE:

7700 Forsyth Blvd., St Louis, MO 63105
Tel.: 3147254477

INCORPORATED:

Delaware

INDUSTRY (SEC SIC CODE):

6324 · Hospital & Medical Service Plans

FILER STATUS:

Large accelerated filer

LATEST ANNUAL REPORT:

10-K for period ended 12/31/25, filed 17 February 2026

RECENT FILINGS (ANNUAL REPORT REFERENCES BELOW):

10/8/26	8-K	period 10/8/26
9/16/26	8-K	period 9/16/26
8/17/26	8-K	period 8/12/26
7/29/26	8-K	period 7/29/26
7/28/26	8-K	period 7/28/26
7/28/26	10-Q	period 6/30/26
6/22/26	8-K	period 6/19/26
5/15/26	8-K	period 5/12/26

Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/17/26) · 10-K FY2024 (filed 2/18/25) · 10-K FY2023 (filed 2/20/24) · 10-K FY2022 (filed 2/21/23) · 10-K FY2021 (filed 2/22/22) · 10-K FY2020 (filed 2/22/21) · 10-K FY2019 (filed 2/18/20) · 10-K FY2018 (filed 2/19/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.